Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Article information

Diabetes Metab J. 2021;45(4):621-621

Publication date (electronic) : 2021 July 30

doi : https://doi.org/10.4093/dmj.2021.0119

Division of Endocrinology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Diabetes Metab J 2021;45:337-338. https://doi.org/10.4093/dmj.2021.0078

In this article, “fasting C-peptide level was higher in the subpopulation” has been corrected to “fasting C-peptide level was lower in the subpopulation” in the 3rd paragraph. This manuscript has been corrected in the online versions. We apologize for any inconvenience that this may have caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.